

| Número de catálogo | DB199018 |
|---|---|
| Descripción |
Letolizumab ELISA Kit (DB199018) — Quantitative sandwich ELISA for Letolizumab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| Tipo de muestra | Plasma, Serum |
| Sensibilidad | 0.156 μg/ml |
| Rango | 0.31-5 μg/mL |
| Número de acceso | P29965 |
| Aplicaciones | ELISA |
| Método de detección | Colorimetric |
| Tipo de ensayo | Quantitative |
| Recuperación | 80-120% |
| Envío | 2-8 ℃ |
| Estabilidad y almacenamiento | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| Especificaciones | Letolizumab |
| Nombres alternativos | BMS-986004, 1450981-87-9 |
| Fondo | CD40 ligand (Letolizumab) is a ~29 kDa protein. Cytokine that acts as a ligand to CD40/TNFRSF5. Costimulates T-cell proliferation and cytokine production. Its cross-linking on T-cells generates a costimulatory signal which enhances the production of IL4 and IL10 in conjunction with the TCR/CD3 ligation and CD28 costimulation. Induces the activation of NF-kappa-B. Induces the activation of kinases MAPK8 and PAK2 in T-cells. 1. Graf, D. et al. (1992) European journal of immunology 22, 3191-4. PMID: 1280226 2. Takada, YK. et al. (2019) Journal of immunology (Baltimore, Md. : 1950) 203, 1383-1391. PMID: 31331973 3. Blotta, MH. et al. (1996) Journal of immunology (Baltimore, Md. : 1950) 156, 3133-40. PMID: 8617933 4. Mikolajczak, SA. et al. (2004) The Journal of experimental medicine 199, 1025-31. PMID: 15067037 |
| Nota | For Research Use Only. |




Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.
Correo: [email protected]
+86-027-65523339
Edificio C, No. 666, Calle Shendunsi, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский